Your browser doesn't support javascript.
loading
Diabetes Mellitus and Tuberculosis Treatment Outcomes in Pune, India.
Mave, Vidya; Gaikwad, Sanjay; Barthwal, Madhusudan; Chandanwale, Ajay; Lokhande, Rahul; Kadam, Dileep; Dharmshale, Sujata; Bharadwaj, Renu; Kagal, Anju; Pradhan, Neeta; Deshmukh, Sona; Atre, Sachin; Sahasrabudhe, Tushar; Meshram, Shailesh; Kakrani, Arjun; Kulkarni, Vandana; Raskar, Swapnil; Suryavanshi, Nishi; Kornfeld, Hardy; Dooley, Kelly E; Chon, Sandy; Gupte, Akshay; Gupta, Amita; Gupte, Nikhil; Golub, Jonathan E.
Afiliação
  • Mave V; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
  • Gaikwad S; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Barthwal M; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
  • Chandanwale A; Byramjee-Jeejeebhoy Government Medical College, Pune, India.
  • Lokhande R; Dr. D.Y. Patil Medical College, Hospital & Research Centre, Dr. D.Y. Patil Vidyapeeth, Pune, India.
  • Kadam D; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
  • Dharmshale S; Byramjee-Jeejeebhoy Government Medical College, Pune, India.
  • Bharadwaj R; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
  • Kagal A; Byramjee-Jeejeebhoy Government Medical College, Pune, India.
  • Pradhan N; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
  • Deshmukh S; Byramjee-Jeejeebhoy Government Medical College, Pune, India.
  • Atre S; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
  • Sahasrabudhe T; Byramjee-Jeejeebhoy Government Medical College, Pune, India.
  • Meshram S; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
  • Kakrani A; Byramjee-Jeejeebhoy Government Medical College, Pune, India.
  • Kulkarni V; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
  • Raskar S; Byramjee-Jeejeebhoy Government Medical College, Pune, India.
  • Suryavanshi N; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
  • Kornfeld H; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
  • Dooley KE; Dr. D.Y. Patil Medical College, Hospital & Research Centre, Dr. D.Y. Patil Vidyapeeth, Pune, India.
  • Chon S; Dr. D.Y. Patil Medical College, Hospital & Research Centre, Dr. D.Y. Patil Vidyapeeth, Pune, India.
  • Gupte A; Dr. D.Y. Patil Medical College, Hospital & Research Centre, Dr. D.Y. Patil Vidyapeeth, Pune, India.
  • Gupta A; Dr. D.Y. Patil Medical College, Hospital & Research Centre, Dr. D.Y. Patil Vidyapeeth, Pune, India.
  • Gupte N; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
  • Golub JE; Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Research Site, Pune, India.
Open Forum Infect Dis ; 8(4): ofab097, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33884278
ABSTRACT

BACKGROUND:

Diabetes mellitus (DM) increases the risk of tuberculosis (TB) disease. Knowledge of the impact of DM on TB treatment outcomes is primarily based on retrospective studies.

METHODS:

We conducted a prospective cohort study of new pulmonary TB patients with and without DM (TB-DM and TB only) in India. The association of DM with a composite unfavorable TB treatment outcome (failure, recurrence, mortality) over 18 months was determined, and the effect of DM on all-cause mortality and early mortality (death during TB treatment) was assessed.

RESULTS:

Of 799 participants, 574 (72%) had TB only and 225 (28%) had TB-DM. The proportion of patients with DM who experienced the composite outcome was 20%, as compared with 21% for TB-only participants (adjusted hazard ratio [aHR], 1.13; 95% CI, 0.75-1.70). Mortality was higher in participants with DM (10% vs 7%), and early mortality was substantially higher among patients with DM (aHR, 4.36; 95% CI, 1.62-11.76).

CONCLUSIONS:

DM was associated with early mortality in this prospective cohort study, but overall unfavorable outcomes were similar to participants without DM. Interventions to reduce mortality during TB treatment among people with TB-DM are needed.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia